place

Ontario Cancer Institute

Hospital buildings completed in 1958Hospital buildings completed in 1995Hospitals established in 1958Hospitals in TorontoMedical organization stubs
Toronto stubs

The Ontario Cancer Institute (OCI) is the research division of Princess Margaret Cancer Centre, affiliated to the University Health Network of the University of Toronto Faculty of Medicine. As Canada's first dedicated cancer hospital, it opened officially and began to receive patients in 1958, although its research divisions had begun work a year earlier. Because, at that time, a stigma was associated with the word "cancer", the hospital was soon renamed the Princess Margaret Hospital, although the whole operation was called the Ontario Cancer Institute incorporating the Princess Margaret Hospital, or OCI/PMH. Clinicians usually preferred the hospital name, while the scientists used OCI. The original location of the OCI/PMH was at 500 Sherbourne Street in Toronto. In 1995, the whole operation moved to a new building at 610 University Avenue, and the new Princess Margaret Hospital became part of the University Health Network. The OCI continued as the research arm of the PMH, that in 2012 changed its name in Princess Margaret Cancer Centre.

Excerpt from the Wikipedia article Ontario Cancer Institute (License: CC BY-SA 3.0, Authors).

Ontario Cancer Institute
University Avenue, Toronto

Geographical coordinates (GPS) Address Nearby Places
placeShow on map

Wikipedia: Ontario Cancer InstituteContinue reading on Wikipedia

Geographical coordinates (GPS)

Latitude Longitude
N 43.658322 ° E -79.390785 °
placeShow on map

Address

Princess Margaret Hospital

University Avenue 610
M5S 3M2 Toronto
Ontario, Canada
mapOpen on Google Maps

Share experience

Nearby Places

Princess Margaret Cancer Centre
Princess Margaret Cancer Centre

The Princess Margaret Cancer Centre (previously, Princess Margaret Hospital) is a scientific research centre and a teaching hospital in Toronto, Ontario, Canada, affiliated with the University of Toronto Faculty of Medicine as part of the University Health Network. The hospital now stands as the largest cancer centre in Canada and one of the five largest cancer centres in the world. Along with the Odette Cancer Centre, which is also associated with University of Toronto Faculty of Medicine and is independently the sixth largest cancer centre in North America, it forms one of the largest cluster of cancer hospitals in the world.The hospital is situated near the intersection of University Avenue and College Street within the Discovery District of downtown Toronto, an area with high concentration of biomedical research institutions. Named for Princess Margaret, Countess of Snowdon, the hospital is under the royal patronage of Anne, Princess Royal. The hospital specializes in the treatment of cancer, and offers the majority of its services to residents of the Greater Toronto Area. The hospital offers expertise in the fields of surgical oncology, medical oncology, hematology including bone marrow transplantation, radiation oncology, psychosocial oncology, medical imaging, and radiation therapy. The hospital houses 17 radiation treatment machines, all of which are equipped with the latest technologies including IMRT and VMAT, a superficial orthovoltage machine, and operates a Gamma Knife (Perfexion) stereotactic radiosurgery machine in collaboration with Toronto Western Hospital.

Mount Sinai Hospital (Toronto)

Mount Sinai Hospital (MSH) is a hospital in Toronto, Ontario, Canada. Mount Sinai is part of Sinai Health. Sinai Health was formed through the voluntary amalgamation of Mount Sinai Hospital (including the Lunenfeld-Tanenbaum Research Institute) and Hennick Bridgepoint Hospital on January 22, 2015. Mount Sinai is linked by bridges and tunnels to three adjacent hospitals of the University Health Network (Toronto General Hospital, Toronto Rehabilitation Institute, and Princess Margaret Cancer Centre). During the 2005 annual charity, the hospital reported to the Canada Revenue Agency as having assets of roughly C$ 520 million. In the 2019-2020 fiscal year there were nearly 29,000 inpatient stays and 59,700 emergency department visits for Mount Sinai Hospital. The average length of stay for inpatients was 4.4 days.Mount Sinai Hospital has existed in Toronto since 1923 under various names; it has occupied its present site on University Avenue since 1953. In the fiscal year ending March 2013, Mount Sinai Hospital cared for 128,714 inpatients days, delivered almost 7,000 babies and performed almost 20,000 surgeries. Toronto and area residents made more than half a million ambulatory clinic visits to Mount Sinai. In that same year, the hospital's Schwartz/Reisman Emergency Department saw 56,080 visits and that number is expected to increase to 80,000 per year over the next few years.More than 600 staff work at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai's research facility. The institute was established in 1985 as the Samuel Lunenfeld Research Institute. On June 24, 2013, it became the Lunenfeld-Tanenbaum Research Institute. Many of its researchers hold faculty appointments at the University of Toronto. In October 2010, Mount Sinai Hospital was named one of Greater Toronto's Top Employers by Mediacorp Canada Inc.Dr. Gary Newton was appointed president and CEO of Mount Sinai Hospital, Sinai Health in October 2016.

Lunenfeld-Tanenbaum Research Institute

The Lunenfeld-Tanenbaum Research Institute is a medical research institute in Toronto, Ontario and part of the Sinai Health System. It was originally established in 1985 as the Samuel Lunenfeld Research Institute, the research arm of Mount Sinai Hospital, by an endowment from the Lunenfeld and Kunin families. It was renamed to the current name on June 24, 2013, after a $35 million donation from Larry and Judy Tanenbaum. It comprises 36 principal investigators, has a budget of C$90 million (2005/6), has over 200 trainees and approximately 600 staff. The institute conducts research into various forms of cancer (colon, breast, pancreatic, prostate, lung, etc.), neurological disorders and brain illnesses, women's and infants' health, diabetes, developmental biology, stem cell biology and tissue regeneration, mouse models of human disease, genomic medicine and systems biology. The institute has 100,000 sq ft (9,300 m2) of space and is split between the main hospital and the Joseph and Wolf Lebovic Health Complex. The Lunenfeld-Tanenbaum Research Institute is a world pioneer in the fields of Systems Biology, Diabetes, and Infectious Bowel Disease. Its Systems Biology team consistently ranked Top 5 worldwide. Researchers at the Lunenfeld have the highest per capita funding and citations in Canada. The founding director was Louis Siminovitch (1984–1994), followed by Alan Bernstein (1995–2000), Janet Rossant and Anthony Pawson (2001–2002), Anthony Pawson (2002–2005) and James Woodgett (2005–).